Literature DB >> 16861677

Reduction of the ganglioside binding activity of the tetanus toxin HC fragment destroys immunogenicity: implications for development of novel tetanus vaccines.

Omar Qazi1, Dorothea Sesardic, Robert Tierney, Zahra Söderbäck, Dennis Crane, Barbara Bolgiano, Neil Fairweather.   

Abstract

In this study, the immunogenicities of the nontoxic H(C) fragment of tetanus toxin and derivatives lacking ganglioside binding activity were compared with that of tetanus toxoid after subcutaneous immunization of mice. Wild-type H(C) (H(C)WT) protein and tetanus toxoid both elicited strong antibody responses against toxoid and H(C) antigens and provided complete protection against toxin challenge. Mutants of H(C) containing deletions essential for ganglioside binding elicited lower responses than H(C)WT. H(C)M115, containing two amino acid substitutions within the ganglioside binding site, provided reduced protection against tetanus toxin challenge compared with H(C)WT, consistent with lower anti-H(C) and anti-toxoid antibody titers. Circular-dichroism spectroscopy and intrinsic fluorescence spectroscopy showed minimal structural perturbation in H(C)M115. We conclude that the presence of the ganglioside binding site within H(C) may be essential for induction of a fully protective anti-tetanus response comparable to that induced by tetanus toxoid by subcutaneous injection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16861677      PMCID: PMC1539629          DOI: 10.1128/IAI.00500-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

Review 1.  Tetanus.

Authors:  J J Farrar; L M Yen; T Cook; N Fairweather; N Binh; J Parry; C M Parry
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-09       Impact factor: 10.154

2.  The crystal structure of tetanus toxin Hc fragment complexed with a synthetic GT1b analogue suggests cross-linking between ganglioside receptors and the toxin.

Authors:  C Fotinou; P Emsley; I Black; H Ando; H Ishida; M Kiso; K A Sinha; N F Fairweather; N W Isaacs
Journal:  J Biol Chem       Date:  2001-06-19       Impact factor: 5.157

3.  Bacterial spores as vaccine vehicles.

Authors:  Le H Duc; Huynh A Hong; Neil Fairweather; Ezio Ricca; Simon M Cutting
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

4.  Expression of tetanus toxin Fragment C in tobacco chloroplasts.

Authors:  John S Tregoning; Peter Nixon; Hiroshi Kuroda; Zora Svab; Simon Clare; Frances Bowe; Neil Fairweather; Jimmy Ytterberg; Klaas J van Wijk; Gordon Dougan; Pal Maliga
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

5.  Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C.

Authors:  C O Tacket; J Galen; M B Sztein; G Losonsky; T L Wyant; J Nataro; S S Wasserman; R Edelman; S Chatfield; G Dougan; M M Levine
Journal:  Clin Immunol       Date:  2000-11       Impact factor: 3.969

6.  Analysis of mutants of tetanus toxin Hc fragment: ganglioside binding, cell binding and retrograde axonal transport properties.

Authors:  K Sinha; M Box; G Lalli; G Schiavo; H Schneider; M Groves; G Siligardi; N Fairweather
Journal:  Mol Microbiol       Date:  2000-09       Impact factor: 3.501

7.  Assessment of the stability and immunogenicity of meningococcal oligosaccharide C-CRM197 conjugate vaccines.

Authors:  M M Ho; B Bolgiano; M J Corbel
Journal:  Vaccine       Date:  2000-11-22       Impact factor: 3.641

8.  Two carbohydrate binding sites in the H(CC)-domain of tetanus neurotoxin are required for toxicity.

Authors:  Andreas Rummel; Steffen Bade; Jürgen Alves; Hans Bigalke; Thomas Binz
Journal:  J Mol Biol       Date:  2003-02-21       Impact factor: 5.469

9.  The structures of the H(C) fragment of tetanus toxin with carbohydrate subunit complexes provide insight into ganglioside binding.

Authors:  P Emsley; C Fotinou; I Black; N F Fairweather; I G Charles; C Watts; E Hewitt; N W Isaacs
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

10.  Transcutaneous immunization with tetanus toxoid and mutants of Escherichia coli heat-labile enterotoxin as adjuvants elicits strong protective antibody responses.

Authors:  Rob Tierney; Anne-Sophie Beignon; Rino Rappuoli; Sylviane Muller; Dorothea Sesardic; Charalambos D Partidos
Journal:  J Infect Dis       Date:  2003-08-11       Impact factor: 5.226

View more
  7 in total

1.  A conformational change of C fragment of tetanus neurotoxin reduces its ganglioside-binding activity but does not destroy its immunogenicity.

Authors:  Rui Yu; Shaoqiong Yi; Changming Yu; Ting Fang; Shuling Liu; Ting Yu; Xiaohong Song; Ling Fu; Lihua Hou; Wei Chen
Journal:  Clin Vaccine Immunol       Date:  2011-08-03

2.  Identification of a unique ganglioside binding loop within botulinum neurotoxins C and D-SA .

Authors:  Andrew P-A Karalewitz; Abby R Kroken; Zhuji Fu; Michael R Baldwin; Jung-Ja P Kim; Joseph T Barbieri
Journal:  Biochemistry       Date:  2010-09-21       Impact factor: 3.162

3.  The recombinant protein combined vaccine based on the fragment C of tetanus toxin and the cross-reacting material 197.

Authors:  Pengdi Chai; Xiuying Pu; Jun Ge; Sulin Ren; Xiaoyu Xia; Amiao Luo; Shiwei Wang; Xiaodong Wang; Jianqiang Li
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-29       Impact factor: 4.813

Review 4.  Unique ganglioside binding by botulinum neurotoxins C and D-SA.

Authors:  Abby R Kroken; Andrew P-A Karalewitz; Zhuji Fu; Michael R Baldwin; Jung-Ja P Kim; Joseph T Barbieri
Journal:  FEBS J       Date:  2011-05-31       Impact factor: 5.542

5.  Enhancing the protective immune response against botulism.

Authors:  Amanda Przedpelski; William H Tepp; Abby R Kroken; Zhuji Fu; Jung-Ja P Kim; Eric A Johnson; Joseph T Barbieri
Journal:  Infect Immun       Date:  2013-05-13       Impact factor: 3.441

Review 6.  Tetanus Toxin Fragment C: Structure, Drug Discovery Research and Production.

Authors:  Caroline Bayart; Angélique Mularoni; Nada Hemmani; Soumeya Kerachni; Joachim Jose; Patrice Gouet; Joseph Paladino; Marc Le Borgne
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-17

7.  Tetanus Neurotoxin Neutralizing Antibodies Screened from a Human Immune scFv Antibody Phage Display Library.

Authors:  Han Wang; Rui Yu; Ting Fang; Ting Yu; Xiangyang Chi; Xiaopeng Zhang; Shuling Liu; Ling Fu; Changming Yu; Wei Chen
Journal:  Toxins (Basel)       Date:  2016-09-11       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.